Add a bookmark to get started

Stephen Matthews

Stephen C. Matthews


Stephen C. Matthews is a seasoned litigator and trial attorney with over 25 years of experience in complex litigation with a focus on product liability, tort and complex commercial matters in various industries, including, life sciences and healthcare. Stephen has served as national counsel in several mass tort and class action litigations and brings to bear significant experience to help devise early resolution strategies. Stephen has experience with direct defense of aging services facilities in lawsuits asserting professional liability, personal injury, negligence, elder abuse, wrongful death and other related claims.

Stephen also regularly counsels clients on a wide-range of regulatory, risk management, due-diligence, product labeling, policy and crisis-management issues.

Bar admissionsNew Jersey
CourtsUnited States District Court for the District of New JerseySupreme Court of the United StatesUnited States Court of Appeals for the First CircuitUnited States Court of Appeals for the Third CircuitUnited States District Court for the Northern District of New YorkUnited States District Court for the Southern District of New YorkUnited States District Court for the Eastern District of New YorkUnited States District Court for the Western District of New York
  • J.D., Catholic University of America
  • B.A., Political Theory, Catholic University of America


  • Chambers USA
    • Band 3, New Jersey Litigation: Product Liability (2021-2023)
  • The Legal 500 United States
    • Recommended, Healthcare: Life Sciences (2020) 
    • Recommended, Product Liability, Mass Tort and Class Action: Pharmaceuticals and Medical Devices - Defense (2019) 
For more information, pursuant to New Jersey Lawyer Advertising guidance, please click here.


  • "Protecting Disabled Veterans in Need of Financial Assistance," ABI Journal, December 2019, reprinted in Best of ABI 2019: The Year in Consumer Bankruptcy March 2020
  • "Law Firms as Business Associates - Is Your Firm HIPAA Compliant?" New Jersey Lawyer, June 2014
  • "FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement," Association of Corporate Counsel, May 23, 2013
  • "New Jersey Court Rejects 'Innovator Liability' for Brand-name Drug Manufacturers," Association of Corporate Counsel, June 29, 2012
  • Contributing Author, "The New Reality of Sales Force Behavior and Management," FDLI Monograph Series, Vol. 2, Num 6, June 2011
  • "New Jersey Supreme Court Rejects Consumer Fraud Class Action for Prescription Drug Plans," Porzio Litigation Update, September 12, 2007 and New Jersey Defense, Vol. 24, Issue 2, April 2008


  • "Fireside Chat: Ensuring Access to the Next Horizon of Therapies," BioNJ C-Suite Summit, November 8, 2019
  • Moderator, "Managing Legal and Ethical Considerations, the Challenges for In House Counsel," ACCNJ, September 20, 2019
  • "Class Action Blockbuster: Key Developments in Consumer Class Litigation," ABA Tort Trial and Insurance Practice Section, May 4, 2018
  • "Key Issues Facing Device Manufacturers 510k and PMA," ABA/TIPS Life Sciences Conference, September 2017
  • "Off Label Marketing and Free Speech in the Post Caronia and Amarin World," ABA/TIPS Life Sciences Conference, September 2016
  • "Life Sciences Litigation and Compliance Update," PLAC Spring Meeting, April 2016
  • "Litigation Update for the Medical Device Industry," West Coast Compliance Congress, November 14, 2014
  • "Emerging Issues in New Jersey Ethics: Pitfalls in Witness Prep, Use of Social Media & The Growth of Alternative Fee Agreements," Trial Attorneys of New Jersey, MCLE Seminar & Annual Meeting, June 7, 2012



+1 973 520 2541
(Work, New Jersey (Short Hills))